338 related articles for article (PubMed ID: 7492752)
1. A human-mouse chimeric Lym-1 monoclonal antibody with specificity for human lymphomas expressed in a baculovirus system.
Hu P; Glasky MS; Yun A; Alauddin MM; Hornick JL; Khawli LA; Epstein AL
Hum Antibodies Hybridomas; 1995; 6(2):57-67. PubMed ID: 7492752
[TBL] [Abstract][Full Text] [Related]
2. A chimeric Lym-1/interleukin 2 fusion protein for increasing tumor vascular permeability and enhancing antibody uptake.
Hu P; Hornick JL; Glasky MS; Yun A; Milkie MN; Khawli LA; Anderson PM; Epstein AL
Cancer Res; 1996 Nov; 56(21):4998-5004. PubMed ID: 8895756
[TBL] [Abstract][Full Text] [Related]
3. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA
Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462
[TBL] [Abstract][Full Text] [Related]
4. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK
Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354
[TBL] [Abstract][Full Text] [Related]
5. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
[TBL] [Abstract][Full Text] [Related]
6. Antibody-dependent, cell-mediated cytotoxicity by an anti-class II murine monoclonal antibody: effects of recombinant interleukin 2 on human effector cell lysis of human B-cell tumors.
Biddle WC; Pancook J; Goldrosen M; Han T; Foon KA; Vaickus L
Cancer Res; 1990 May; 50(10):2991-6. PubMed ID: 2334902
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen.
Shaw DR; Khazaeli MB; Sun LK; Ghrayeb J; Daddona PE; McKinney S; LoBuglio AF
J Immunol; 1987 Jun; 138(12):4534-8. PubMed ID: 3584980
[TBL] [Abstract][Full Text] [Related]
8. Generation and characterization of a recombinant/chimeric B72.3 (human gamma 1).
Hutzell P; Kashmiri S; Colcher D; Primus FJ; Hand PH; Roselli M; Finch M; Yarranton G; Bodmer M; Whittle N
Cancer Res; 1991 Jan; 51(1):181-9. PubMed ID: 1988082
[TBL] [Abstract][Full Text] [Related]
9. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
Coney LR; Mezzanzanica D; Sanborn D; Casalini P; Colnaghi MI; Zurawski VR
Cancer Res; 1994 May; 54(9):2448-55. PubMed ID: 7512887
[TBL] [Abstract][Full Text] [Related]
10. Engineering and characterization of a baculovirus-expressed mouse/human chimeric antibody against transferrin receptor.
Shen X; Hu GB; Jiang SJ; He FR; Xing W; Li L; Yang J; Zhu HF; Lei P; Shen GX
Protein Eng Des Sel; 2009 Dec; 22(12):723-31. PubMed ID: 19825853
[TBL] [Abstract][Full Text] [Related]
11. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
[TBL] [Abstract][Full Text] [Related]
12. A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen.
Sahagan BG; Dorai H; Saltzgaber-Muller J; Toneguzzo F; Guindon CA; Lilly SP; McDonald KW; Morrissey DV; Stone BA; Davis GL
J Immunol; 1986 Aug; 137(3):1066-74. PubMed ID: 3088107
[TBL] [Abstract][Full Text] [Related]
13. Antigen binding and biological activities of engineered mutant chimeric antibodies with human tumor specificities.
Gillies SD; Wesolowski JS
Hum Antibodies Hybridomas; 1990; 1(1):47-54. PubMed ID: 2129419
[TBL] [Abstract][Full Text] [Related]
14. The production and preclinical characterization of a chimeric anti-breast-cancer antibody, cBC2.
Sutton VR; Burgess J; Pietersz GA; Li WJ; McKenzie IF; Trapani JA
Ther Immunol; 1994 Apr; 1(2):83-93. PubMed ID: 7584487
[TBL] [Abstract][Full Text] [Related]
15. High-level expression and characterization of a mouse-human chimeric CD4 antibody with therapeutic potential.
Looney JE; Knight DM; Arevalo-Moore M; Trinh H; Pak KY; Dalesandro MR; Rieber EP; Riethmuller G; Daddona PE; Ghrayeb J
Hum Antibodies Hybridomas; 1992 Oct; 3(4):191-200. PubMed ID: 1477300
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of the specificity of a rat monoclonal anti-idiotype antibody, WN, to an anti-B-cell lymphoma monoclonal antibody, LL2.
Losman MJ; Leung SO; Shih LB; Shevitz J; Shukla R; Haraga L; Goldenberg DM; Hansen HJ
Cancer Res; 1995 Dec; 55(23 Suppl):5978s-5982s. PubMed ID: 7493380
[TBL] [Abstract][Full Text] [Related]
17. Chimeric mouse-human anti-carcinoma antibodies that mediate different anti-tumor cell biological activities.
Robinson RR; Chartier J; Chang CP; Horwitz AH; Better M
Hum Antibodies Hybridomas; 1991 Apr; 2(2):84-93. PubMed ID: 1873500
[TBL] [Abstract][Full Text] [Related]
18. Recombinant mouse/human chimeric anti-colorectal carcinoma antibody cACT19.
Xiang J; Moyana T; Liu E
Hum Antibodies Hybridomas; 1994; 5(3-4):105-15. PubMed ID: 7756575
[TBL] [Abstract][Full Text] [Related]
19. Humanized anti-Lewis Y antibodies: in vitro properties and pharmacokinetics in rhesus monkeys.
Co MS; Baker J; Bednarik K; Janzek E; Neruda W; Mayer P; Plot R; Stumper B; Vasquez M; Queen C; Loibner H
Cancer Res; 1996 Mar; 56(5):1118-25. PubMed ID: 8640770
[TBL] [Abstract][Full Text] [Related]
20. [Expression of human-mouse chimeric antibody ch-BD1 and its affinity to human bladder cancer in vitro and in vivo].
Bai Y; Yu LZ; Lü YQ; Ai JK; Zhou LJ; Zhang CL; Wang Y
Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(4):333-7. PubMed ID: 12812655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
